Publications by authors named "M Cleman"
Background: Early studies on transcatheter aortic valve replacement (TAVR) outcomes showed that female sex was associated with better survival. With increased use of new-generation valves, the impact of sex on contemporary TAVR outcomes is less well known.
Methods: Retrospective analysis using institutional National Cardiovascular Data Registry STS/ACC TVT data was performed on all patients undergoing TAVR at Yale New Haven Hospital from July 2012 to August 2019.
Background: Transcatheter aortic valve replacement (TAVR) is known to increase the incidence of conduction disturbances compared to surgical aortic valve replacement; however, there are limited data on the impact and duration of these conduction disturbances on longer term outcomes.
Objective: To determine the differential impact of persistent versus nonpersistent new-onset conduction disturbances on TAVR-related complications and outcomes.
Methods: This is a single-center retrospective analysis of 927 consecutive patients with aortic stenosis who underwent TAVR at Yale New Haven Hospital from July 2012 to August 2019.
Article Synopsis
- - The study aimed to determine the impact of colchicine and high-intensity rosuvastatin on the progression of COVID-19 in hospitalized patients, compared to standard care alone.
- - Conducted as a randomized controlled trial across four centers within the Yale New Haven Health System, it involved 250 non-critically ill hospitalized COVID-19 patients, with a follow-up period of 30 days.
- - The trial was halted early for futility, as there was no notable difference in severe disease progression or thromboembolic events between the treatment group and the control group.
Objectives: We sought to examine readmission rates and predictors of hospital readmission following TAVR in patients with ESRD.
Background: End-stage renal disease (ESRD) is associated with poor outcomes following transcatheter aortic valve replacement (TAVR).
Methods: We assessed index hospitalizations for TAVR from the National Readmissions Database from 2017 to 2018 and used propensity scores to match those with and without ESRD.
Background/purpose: The prevalence of dementia and aortic stenosis (AS) increases with each decade of age. Transcatheter aortic valve replacement (TAVR) is a definitive treatment for AS, but there are scarce data on morbidity, mortality, and readmission risk after TAVR in patients with dementia.
Methods/materials: We identified all admissions for TAVR in patients with AS in the National Readmissions Database in 2017-2018 and stratified them according to the presence or absence of a secondary diagnosis of dementia.